4 Results for "

CDK2-IN-8

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "CDK2-IN-8" in MCE Product Catalog:

Cat. No.: HY-144810
CAS No.: 2919216-36-5
Target:  

CDK

Research Areas:  

Cancer

CDK2-IN-8 is a potent CDK2 inhibitor with an IC50 of 1.74 µM. CDK2-IN-8 shows antiproliferative activity. CDK2-IN-8 has the potential for the research of melanoma .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-112626
CAS No.: 2244987-03-7
Purity:  99.36%
Target:  

CDK

Research Areas:  

Cancer

CDK12-IN-2 is a potent, selective and nanomolar CDK12 inhibitor (IC50=52 nM) with good physicochemical properties. CDK12-IN-2 is also a strong CDK13 inhibitor due to CDK13 is the closest homologue of CDK12. CDK12-IN-2 shows excellent kinase selectivity for CDK12 over CDK2, 9, 8, and 7. CDK12-IN-2 inhibits the phosphorylation of Ser2 in the C-terminal domain of RNA polymerase II. CDK12-IN-2 can be used an excellent chemical probe for functional studies of CDK12 .
loading...
    loading...
Cat. No.: HY-178007
CAS No.: 3099145-52-2
Target:  

CDK

Research Areas:  

Cancer

CDK2 degrader 8 (Compound1) is a CDK2 degrader. CDK2 degrader 8 shows potential anti-tumor activity by targeting CDK2. CDK2 degrader 8 can be used for the study of solid tumors (breast cancer, triple negative breast cancer, ovarian serous cystadenocarcinoma) and liquid tumors (diffuse large B-cell lymphoma, acute myelogenous leukemia) associated with abnormal CDK2 function .
loading...
    loading...
Cat. No.: HY-175013
CAS No.: 3068529-24-5
Research Areas:  

Inflammation/Immunology

CDK6/9-IN-2 is a highly active dual inhibitor of CDK6 (IC50 = 15 nM) and CDK9 (IC50 = 22 nM). CDK6/9-IN-2 is selective for CDK2, CDK8, and CDK11. CDK6/9-IN-2 inhibits the proliferation of HaCaT cells induced by IFN-γ/TNF-α and suppresses the STAT3 pathway and the expression of inflammatory factors. CDK6/9-IN-2 can alleviate psoriatic dermatitis and is useful in psoriasis research .
loading...
    loading...